Affiliated Forum I

updated on 7 September 2026

AF.I – From Discovery to Translation: Integrating Fast-Track Innovation, Advanced Delivery Systems, and Data-Driven Precision Nanomedicine
AF.II – Advanced Materials for Space: Research Results, Industrial Impact and Future Directions
AF.III – Application Workshop on Digital and 3D Confocal Microscopy and Laser Probe Profilometry with Nanometric Resolution
AF.IV – Forum PNRR Sapienza
AF.V – Cultural Heritage

CLOISTER ROOM

AF.I From discovery to translation: integrating fast-track innovation, advanced delivery systems, and data-driven precision nanomedicine *14 september*
The Italian Nanomedicine Platform (INP) brings its conversation to NanoInnovation 2026. On September 14^th, join the affiliated forum where science meets strategy and ideas move closer to real-world impact. Across four dedicated sessions, the forum will unite researchers, innovators, and industry stakeholders to cover the full nanomedicine innovation pipeline: Targeting, Delivery & Biomaterials Fast-Track Discovery, Early Tech Transfer & Advanced Characterisation Engineering, Late-Stage Tech Transfer & Regulatory Affairs Precision Nanomedicine, Omics & Data Integration Forum participants can submit a poster abstract for a dedicated INP poster session on September 14^th - and enjoy a 30% discount on submissions to the main NanoInnovation poster session. Registration fee: € 60 + VAT. To sign up and access the full programme, payment options, and submission guidelines, visit the dedicated page on the NanoItaly Association website: www.nanoitalyassociation.org
Co-organised with

This workshop, organised by the Italian Nanomedicine Platform, brings together leading researchers, innovators, and industry stakeholders in the field. The event highlights projects from platform members while fostering interaction with the broader scientific and economic ecosystem interested in nanomedicine. Renowned key speakers will provide high-level insights into current challenges and emerging opportunities. Covering the full innovation pipeline—from targeting and advanced delivery systems to tech transfer, scale-up, regulatory pathways, and data-driven precision approaches—the workshop offers a unique platform to connect discovery with real-world application and impact.


Session I Fast-Track Discovery, Early Tech Transfer & Advanced Characterization 11:00 - 12:30
Chair: Giovanni TOSI, University of Modena and Reggio Emilia & Marzia BEDONI, IRCCS Fond. Don Carlo Gnocchi ETS
Dedicated to accelerating the path from fundamental research to early application, this session covers rapid screening technologies, advanced in vitro and in silico models, and cutting-edge characterization techniques. It also addresses early-stage tech transfer, from proof-of-concept to IP generation and valorization.
11:00 12:30	Graciana DIEZ ROUX - CV Scientific Director at Fondazione Telethon Telethon: from research to patients
	María DE LA FUENTE - CV Co-founder and CEO Diversa The role of industry in translating nanomedicine. The value of SMEs
	Ilaria TONAZZINI CNR Nanoscience Institute / NEST-SNS, Pisa PLGA-based nanovectors for nose-to-brain delivery of antisense oligonucleotides
	Anna Rita BILIA Università di Firenze (co-aff. Università di Genova) DoE and molecular dynamics approaches as a rational design to develop optimised nanovesicles loaded with cannabidiol as a model drug
12:30 - 14:00 lunch
Session II Engineering, Late-Stage Tech Transfer & Regulatory Affairs 14:00 - 15:30
Chair: Valentina CAUDA, Polytechnic University of Turin & Fabiana QUAGLIA, University of Naples
This session explores the transition toward industrial and clinical implementation, including process engineering, scale-up, and standardization. Key topics include late-stage tech transfer, industry collaboration, and regulatory strategies such as EMA/FDA frameworks, Quality by Design, and clinical approval pathways.
PANELISTS
14:00 15:30	Eleonora AGRICOLA & Barbara BONAMASSA Innovation and Scientific Advice EMA & Agenzia Italiana del Farmaco - AIFA Title in definition
	Charalampos KOUTSOULAS - CV Director QA Protein Modality BioNtech From Bench to GMP: Applying Quality by Design for Successful Translation
	Federico PURIFICATO Normal School of Pisa / IIT Hybrid Boron-Gold Nanoarchitectures for Boron Neutron Capture Therapy
	Raffaella PECCI Italian National Institute of Health (ISS) GelMA -based nanocomposite film loaded with Neomycin sulphate and Carvacrol in Halloysite nanotubes against Staphylococcus aureus skin infections
15:30 - 16:00 break
Session III Precision Nanomedicine, Omics & Data Integration 16:00 - 17:15
Chair: Gianfranco PASUT, University of Padua & Fabio PALUMBO, University of Palermo
Focusing on data-driven and personalized approaches, this session highlights the integration of omics data and the use of AI and computational tools for target identification, nanomedicine optimization, and predictive modeling.
16:00 17:15	Teresa MUSUMECI Università di Catania Nanoplatforms supporting brain targeting after intranasal administration for cognitive impairment associated with metabolic syndrome
	Valentina MANGOLINI IRCCS Fond. Don Carlo Gnocchi ETS, Milano Toward non-invasive stratification of neurodegenerative disorders through Raman analysis ofsalivary extracellular vesicles
	Loredana RICCIARDI CNR-NANOTEC, Rende (CS) External stimuli-responsive aptamer-decorated nanoplatforms targeting tumor and stromal cells in breast cancer derived organoids
	Matteo MARZI Università di Padova e Fond. Città della Speranza From Exploratory Research to Functional Diagnostics: Scalability and Standardization of CRISPR/Cas9 Pipelines for Resistance Profiling
	Diego DI GIROLAMO Università Roma Tor Vergata (Startnetics) Mechanistic Dermal PBPK Modeling for the Dermatokinetic Risk Assessment of Persistent Pigment Particles
	Carla SARDO Università degli Studi di Salerno Green-synthesized MnO₂@INU-g-bPEI nanoparticles per siRNA delivery e MRI-guided theranostics


Session IV Targeting, Delivery & Biomaterials 17:15 - 18:30
Chair: Gennara CAVALLARO, University of Palermo & Ilaria OTTONELLI, University of Modena and Reggio Emilia
This session focuses on advanced strategies to enhance therapeutic performance through selective targeting, innovative drug delivery systems, and next-generation biomaterials. Emphasis will be placed on understanding bio–material interactions, including biodistribution, biocompatibility, and efficacy.
17:15 18:30	Calogero FIORICA University of Palermo Chemically Programmable Wet-Electrospun Pullulan based Fibers for Multifunctional 3D Regenerative Scaffolds
	Eleonora D'INTINO Sapienza Università di Roma Liposomal delivery of STING agonist diABZI: Formulation, Characterization, and Induction of Type I Interferon Responses in Mouse and Human Tumor-Immune Models
	Riccardo CARAFFI Università di Modena e Reggio Emilia LNP-Mediated Base Editing for the Treatment of Retinal Degenerations